CGM 衍生指标——血糖管理指标，在评估非白种糖尿病个体的血糖控制中的作用。
Usefulness of CGM-Derived Metric, the Glucose Management Indicator, to Assess Glycemic Control in Non-White Individuals With Diabetes.
机构信息
Joslin Diabetes Center, Boston, MA
Beth Israel Deaconess Medical Center, Boston, MA.
出版信息
Diabetes Care. 2021 Dec;44(12):2787-2789. doi: 10.2337/dc21-1373. Epub 2021 Oct 11.
Abstract
OBJECTIVE
To assess the relationship between the glucose management indicator (GMI) and HbA in non-White individuals with diabetes.
RESEARCH DESIGN AND METHODS
We performed a retrospective analysis of continuous glucose monitoring metrics in individuals with diabetes divided by race into non-White and White cohorts.
RESULTS
We evaluated 316 individuals (non-White = 68; White = 248). Although GMI was not different (7.6 vs. 7.7; = not significant) between the cohorts, HbA was higher in the non-White cohort (8.7% vs. 8.1%; = 0.004). HbA higher than GMI by ≥0.5% was more frequently observed in the non-White cohort (90% vs. 75%; = 0.02). In the non-White cohort only, duration of hypoglycemia was longer among those with HbA higher than GMI by ≥0.5% compared with those with HbA and GMI within 0.5%.
CONCLUSIONS
A differential relationship between HbA and GMI in non-White versus White individuals with diabetes was observed. In non-White individuals, a greater difference between HbA and GMI was associated with higher risk of hypoglycemia.
摘要
目的
评估血糖管理指标（GMI）与糖尿病非白种人群中 HbA 的关系。
研究设计和方法
我们对按种族分为非白种人和白种人队列的糖尿病患者的连续血糖监测指标进行了回顾性分析。
结果
我们评估了 316 名患者（非白种人=68 人；白种人=248 人）。尽管两个队列的 GMI 没有差异（7.6 与 7.7；=无统计学意义），但非白种人队列的 HbA 更高（8.7%与 8.1%；=0.004）。HbA 比 GMI 高≥0.5%的情况在非白种人队列中更为常见（90%与 75%；=0.02）。仅在非白种人队列中，HbA 比 GMI 高≥0.5%的患者的低血糖持续时间长于 HbA 和 GMI 均在 0.5%以内的患者。
结论
在患有糖尿病的非白种人和白种人个体中，HbA 和 GMI 之间存在差异关系。在非白种人个体中，HbA 和 GMI 之间的差异越大，低血糖的风险越高。
相似文献
1
Usefulness of CGM-Derived Metric, the Glucose Management Indicator, to Assess Glycemic Control in Non-White Individuals With Diabetes.CGM 衍生指标——血糖管理指标，在评估非白种糖尿病个体的血糖控制中的作用。
Diabetes Care. 2021 Dec;44(12):2787-2789. doi: 10.2337/dc21-1373. Epub 2021 Oct 11.
2
Discordance Between Glycated Hemoglobin A1c and the Glucose Management Indicator in People With Diabetes and Chronic Kidney Disease.糖化血红蛋白 A1c 与慢性肾脏病糖尿病患者血糖管理指标的不相符。
J Diabetes Sci Technol. 2023 Nov;17(6):1553-1562. doi: 10.1177/19322968221092050. Epub 2022 Apr 25.
3
Usefulness of glucose management indicator derived from continuous glucose monitoring to assess glycemic condition in hospitalized patients with diabetic kidney disease treated with insulin pumps.应用连续血糖监测衍生的葡萄糖管理指标评估接受胰岛素泵治疗的合并糖尿病肾病住院患者的血糖状况。
J Diabetes Complications. 2023 Nov;37(11):108613. doi: 10.1016/j.jdiacomp.2023.108613. Epub 2023 Sep 18.
4
Discordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without Diabetes.非糖尿病患者血糖管理指标与糖化血红蛋白之间的不一致性
Diabetes Technol Ther. 2023 May;25(5):324-328. doi: 10.1089/dia.2022.0544. Epub 2023 Mar 3.
5
The Relationship Between CGM-Derived Metrics, A1C, and Risk of Hypoglycemia in Older Adults With Type 1 Diabetes.1型糖尿病老年患者中持续葡萄糖监测衍生指标、糖化血红蛋白与低血糖风险之间的关系
Diabetes Care. 2020 Oct;43(10):2349-2354. doi: 10.2337/dc20-0016. Epub 2020 May 27.
6
Evaluation of HbA1c and glucose management indicator discordance in a population of children and adolescents with type 1 diabetes.评价 1 型糖尿病患儿和青少年人群中糖化血红蛋白（HbA1c）和血糖管理指标的不相符情况。
Pediatr Diabetes. 2022 Feb;23(1):84-89. doi: 10.1111/pedi.13299. Epub 2021 Dec 15.
7
An Examination of the Glucose Management Indicator in Young Children with Type 1 Diabetes.1型糖尿病幼儿的血糖管理指标研究
J Diabetes Sci Technol. 2022 Nov;16(6):1505-1512. doi: 10.1177/19322968211023171. Epub 2021 Jun 7.
8
Glucose Management Indicator for People with Type 1 Asian Diabetes Is Different from That of the Published Equation: Differences by Glycated Hemoglobin Distribution.1 型亚洲糖尿病患者的血糖管理指标与公布的方程不同：糖化血红蛋白分布的差异。
Diabetes Technol Ther. 2021 Nov;23(11):745-752. doi: 10.1089/dia.2021.0185. Epub 2021 Oct 14.
9
The Glucose Management Indicator: Time to Change Course?血糖管理指标：是时候改变方向了？
Diabetes Care. 2024 Jun 1;47(6):906-914. doi: 10.2337/dci23-0086.
10
Use of Flash Glucose Monitoring and Glycemic Control in Patients with Type 2 Diabetes Mellitus Not Treated with an Intensive Insulin Regimen: 1-Year Real-Life Retrospective Cohort Study.应用动态血糖监测和血糖控制治疗未接受强化胰岛素治疗的 2 型糖尿病患者：1 年真实世界回顾性队列研究。
Adv Ther. 2023 Jun;40(6):2855-2868. doi: 10.1007/s12325-023-02508-y. Epub 2023 May 3.
引用本文的文献
1
Ethnic disparities in HbA1c and hypoglycemia among youth with type 1 diabetes: beyond access to technology, social deprivation and mean blood glucose.1型糖尿病青少年中糖化血红蛋白和低血糖的种族差异：超越技术获取、社会剥夺和平均血糖水平
BMJ Open Diabetes Res Care. 2025 Jan 25;13(1):e004369. doi: 10.1136/bmjdrc-2024-004369.
2
Evaluating HbA-to-average glucose conversion with patient-specific kinetic models for diverse populations.评估不同人群患者特异性动力学模型的糖化血红蛋白到平均血糖转换。
Sci Rep. 2024 Sep 27;14(1):22098. doi: 10.1038/s41598-024-72837-7.
3
Can HbA1c Alone Be Safely Used to Guide Insulin Therapy in African Youth with Type 1 Diabetes?HbA1c 能否单独安全地用于指导非洲青少年 1 型糖尿病患者的胰岛素治疗？
Pediatr Diabetes. 2023;2023. doi: 10.1155/2023/1179830. Epub 2023 Apr 24.
4
Glucose values from the same continuous glucose monitoring sensor significantly differ among readers with different generations of algorithm.不同代算法的连续血糖监测传感器的葡萄糖值读数存在显著差异。
Sci Rep. 2024 Mar 1;14(1):5099. doi: 10.1038/s41598-024-55124-3.
5
Determination of Glucose-Independent Racial Disparity in HbA1c for Youth With Type 1 Diabetes in the Era of Continuous Glucose Monitoring.在持续血糖监测时代确定1型糖尿病青少年糖化血红蛋白中与血糖无关的种族差异。
J Diabetes Sci Technol. 2025 Jan;19(1):72-79. doi: 10.1177/19322968231199113. Epub 2023 Sep 12.
6
Racial and Ethnic Differences in the Association Between Mean Glucose and Hemoglobin A1c.种族和民族差异对平均血糖与糖化血红蛋白关联的影响。
Diabetes Technol Ther. 2023 Oct;25(10):697-704. doi: 10.1089/dia.2023.0153. Epub 2023 Aug 2.
7
Clinical application guidelines for blood glucose monitoring in China (2022 edition).中国血糖监测临床应用指南（2022 年版）。
Diabetes Metab Res Rev. 2022 Nov;38(8):e3581. doi: 10.1002/dmrr.3581. Epub 2022 Oct 25.
8
Prediction of Glucose Concentration in Children with Type 1 Diabetes Using Neural Networks: An Edge Computing Application.使用神经网络预测1型糖尿病儿童的血糖浓度：一种边缘计算应用。
Bioengineering (Basel). 2022 Apr 21;9(5):183. doi: 10.3390/bioengineering9050183.
本文引用的文献
1
Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.实时连续血糖监测与接受胰岛素治疗的糖尿病患者的血糖控制和急性代谢事件的关联。
JAMA. 2021 Jun 8;325(22):2273-2284. doi: 10.1001/jama.2021.6530.
2
Comparison of the FreeStyle Libre Pro Flash Continuous Glucose Monitoring (CGM) System and Point-of-Care Capillary Glucose Testing in Hospitalized Patients With Type 2 Diabetes Treated With Basal-Bolus Insulin Regimen.对比利时福瑞诗 Libre Pro 瞬感葡萄糖监测系统和即时毛细血管血糖检测在接受基础-餐时胰岛素方案治疗的 2 型糖尿病住院患者中的应用。
Diabetes Care. 2020 Nov;43(11):2730-2735. doi: 10.2337/dc19-2073. Epub 2020 Jul 8.
3
The Relationship Between CGM-Derived Metrics, A1C, and Risk of Hypoglycemia in Older Adults With Type 1 Diabetes.1型糖尿病老年患者中持续葡萄糖监测衍生指标、糖化血红蛋白与低血糖风险之间的关系
Diabetes Care. 2020 Oct;43(10):2349-2354. doi: 10.2337/dc20-0016. Epub 2020 May 27.
4
The Calculation of the Glucose Management Indicator Is Influenced by the Continuous Glucose Monitoring System and Patient Race.葡萄糖管理指标的计算受到连续血糖监测系统和患者种族的影响。
Diabetes Technol Ther. 2020 Sep;22(9):651-657. doi: 10.1089/dia.2019.0405. Epub 2019 Dec 31.
5
Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring.血糖管理指标（GMI）：一种从连续血糖监测估算 A1C 的新术语。
Diabetes Care. 2018 Nov;41(11):2275-2280. doi: 10.2337/dc18-1581. Epub 2018 Sep 17.
6
Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels.血糖浓度与糖化血红蛋白水平关系中的种族差异。
Ann Intern Med. 2018 Feb 6;168(3):232-233. doi: 10.7326/L17-0589.
7
International Consensus on Use of Continuous Glucose Monitoring.连续血糖监测应用的国际共识
Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600.
8
The Fallacy of Average: How Using HbA Alone to Assess Glycemic Control Can Be Misleading.平均的谬误：仅使用糖化血红蛋白（HbA）来评估血糖控制如何会产生误导。
Diabetes Care. 2017 Aug;40(8):994-999. doi: 10.2337/dc17-0636.
9
Evidence for consistency of the glycation gap in diabetes.糖尿病糖化差值的一致性证据。
Diabetes Care. 2011 Aug;34(8):1712-6. doi: 10.2337/dc10-1767. Epub 2011 Jun 29.
10
Persistence of individual variations in glycated hemoglobin: analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial.糖化血红蛋白个体变异的持续性：来自青少年糖尿病研究基金会连续血糖监测随机试验的数据分析。
Diabetes Care. 2011 Jun;34(6):1315-7. doi: 10.2337/dc10-1661. Epub 2011 Apr 19.
Zotero 插件